https://wiki.stamen.health/index.php?action=history&feed=atom&title=SCI-GroupSCI-Group - Revision history2026-04-15T00:22:49ZRevision history for this page on the wikiMediaWiki 1.42.7https://wiki.stamen.health/index.php?title=SCI-Group&diff=678&oldid=prevAdmin 3julmthh: Created with researched data2026-04-14T20:32:11Z<p>Created with researched data</p>
<p><b>New page</b></p><div>{{DISPLAYTITLE:SCI-Group}}<br />
{{Infobox company<br />
| name = SCI-Group AS<br />
| org_number = 988214205<br />
| founded = 2005-04-20<br />
| employees = Not disclosed<br />
| address = Norway<br />
| industry = 72.100 – Biotechnology research<br />
| website = https://www.sci-group.no<br />
| nht_category = Startup<br />
| description = SCI-Group (Sci-Group AS) is a Norwegian deep tech company developing CryoEmbla — a groundbreaking cryopreservation technology enabling freezing of living cells without or with significantly reduced use of cytotoxic chemical cryoprotectants (like DMSO). Addresses cell therapy, biotechnology, and life sciences. Partnering with research institutions and industry. Vision: set new global standard for safe, efficient, reproducible cryopreservation.<br />
| notes = No disclosed revenue or funding. Founded 2005. Cryopreservation is fundamental to cell therapy, biobanking, and advanced research.<br />
| related_companies = [[Pre Diagnostics]], [[Pharmasum Therapeutics]], [[Norway Health Tech]]<br />
| categories = Norway Health Tech, Startups, Biotechnology, Deep Tech, Life Sciences<br />
| sources = https://www.sci-group.no; https://data.brreg.no/enhetsregisteret/api/enheter/988214205<br />
}}<br />
<br />
== About ==<br />
<br />
SCI-Group AS is a Norwegian deep technology company dedicated to transforming the global cryopreservation industry. Founded in 2005, the company has developed a patented cryopreservation technology.<br />
<br />
== Technology ==<br />
<br />
=== CryoEmbla ===<br />
<br />
CryoEmbla is SCI-Group's patented core technology enabling:<br />
* Cryopreservation of living cells entirely without cytotoxic chemical cryoprotectants<br />
* Significantly reduced use of cryoprotectants compared to conventional methods<br />
* Safe, rapid, and efficient freezing of living cells<br />
* Simplified handling and workflow<br />
* Cryopreservation without DMSO or with strongly reduced DMSO<br />
<br />
Conventional cryopreservation relies heavily on DMSO (dimethyl sulfoxide), which is cytotoxic and requires careful handling. CryoEmbla addresses this fundamental limitation.<br />
<br />
== Applications ==<br />
<br />
* Cell therapy manufacturing<br />
* Biobanking<br />
* Advanced life sciences research<br />
* Broader clinical and industrial use of living cells<br />
<br />
== Strategy ==<br />
<br />
SCI-Group works closely with leading research institutions, industry partners, and investors to accelerate adoption of next-generation cryopreservation.<br />
<br />
== Vision ==<br />
<br />
To set a new global standard for safe, efficient, and reproducible cryopreservation — unlocking value for medicine, science, and society.<br />
<br />
== References ==<br />
<references/><br />
<br />
[[Category:Norway Health Tech]]<br />
[[Category:Startups]]<br />
[[Category:Biotechnology]]<br />
[[Category:Deep Tech]]<br />
[[Category:Life Sciences]]</div>Admin 3julmthh